| Tag | Content |
|---|
EnhancerAtlas ID | HS105-45343 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr2:128380950-128381660 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOS | MA0476.1 | chr2:128381407-128381418 | GATGAGTCACA | - | 6.14 | | JUND | MA0491.1 | chr2:128381407-128381418 | GATGAGTCACA | - | 6.14 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_25368 | chr2:128378983-128386134 | DND41 | | SE_39390 | chr2:128379029-128384202 | Jurkat | | SE_50004 | chr2:128379035-128381109 | RPMI-8402 | | SE_61797 | chr2:128331989-128410775 | Toledo | | SE_66281 | chr2:128379029-128384202 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I127621 | chr2 | 128378984 | 128386136 |
|
Enhancer Sequence | GTACCAGCCA GGCACCCTGC CCGTCAGCCG CCTCCCTCAT ACACCCAGGG AGAGCACCCT 60
GAGGCTCAAG CCCTCTCACC TTTCCAGCCC GGCCACCACC TACCCTCCCA GCTGCCAGGC 120
ACAGCACTGC TTACCCTCCC AGCCACCAGG CACAGGCAGG TGCACACACA CAGAGCAAAC 180
AGCCTTTCCT CCCGCACTCA TATGGTCACC TTGCAGCTGC GCCTCAGCCC CAGCAGTGCC 240
GCATGCACAC CTGGTCCCCC ACCCAGCAGC CACGCACAGA CATCAGGCAC TCACACCAGT 300
CTCCTGCTCC AAACTCCCTC ATGCCCAGGA GCTGTGGACA CCCCTGCAGC AAACATGGAG 360
GGTCACACCA GCACAGACCC TCACCGCCCA CATAGGCACC CCCAATTCCA CGCCCACACC 420
CTCAGACTCA CACACCAGTC ATCCAACCGA GGCGCCGGAT GAGTCACATC GGCCAGACTC 480
ATGTCTGCCT CCTTAGGGAA GGGGCTGCAG GGAGAGTAAT GGGGAGTGGC AGATGGGCCA 540
TTGCTGTGTG GAGAAGCCCT TCAGGTGTCC ACACGGGCTC AGCAGTGTCC ACTCAGCCCA 600
CGCTGGGCTC CAAGGGCCCC AGGCCCTGTC TTCTACGTGC ACACGCTGAC GGTGGGCGTC 660
CCCGTGGGGT GGGGCATGCA ACAGCCGCTA ACCCCTGCTC CCCGACTCTG 710
|
